Inotiv | analyze. answer. advance.
  • About
    • Why Inotiv
    • Leadership
    • News
    • Events
    • Regulatory Compliance
    • Our Commitment to Integrity and Ethical Conduct
  • Services
    • Research and Discovery
      • Computational Toxicology
      • Disease Pharmacology (in vitro and in vivo)
      • DMPK (in vitro and in vivo)
      • Safety Pharmacology
      • Cell and Molecular Biology
      • Discovery Bioanalysis
        • Biomarkers
      • Exploratory Toxicology
        • Toxicogenomics
        • Genetic Toxicology
        • General Toxicology
      • Surgical Models and Medical Device
    • Nonclinical Safety Assessment
      • General Toxicology
      • Safety Pharmacology
      • Genetic Toxicology
      • Regulated Bioanalysis
      • — Biotherapeutics
        • Biomarker
      • DMPK (PK/TK)
      • Developmental and Reproductive Toxicology
      • Carcinogenicity Studies
      • Surgical Models and Medical Device
    • Pathology
      • Histology
      • Digital Pathology
      • Clinical Pathology
      • Medical Device Pathology
    • Bioanalysis
      • Nonregulated Discovery Bioanalysis
      • Regulated Preclinical and Clinical Bioanalysis
      • Biotherapeutics
        • Biomarkers
    • Proteomics
    • Consulting
    • Research Models and Services
  • Insights
  • Contact
  • |
  • Investors
  • Careers
  • VISIT OUR VIRTUAL BOOTH

2017

Corporate News

December 12, 2017

BASi Announces Enhanced Bioequivalence Capabilities

Corporate News

November 13, 2017

Steady Growth Spurs Plans for BASi Expansion of GLP Toxicology Facility in Indiana

Get the Insights You Deserve

Answering the right questions on time and with high-quality data is the key to achieving your objectives. Expect more.

Get In Touch
Inotiv Logo

2701 Kent Avenue
West Lafayette, IN 47906 USA
800.845.4246
765.463.4527

Copyright © 2023 Inotiv. All Rights Reserved.

  • Privacy
  • Accessibility
  • Terms Of Use
  • Contact
  • About
    • Why Inotiv
    • Leadership
    • News
    • Events
    • Regulatory Compliance
    • Our Commitment to Integrity and Ethical Conduct
  • Services
    • Research and Discovery
      • Computational Toxicology
      • Disease Pharmacology (in vitro and in vivo)
      • DMPK (in vitro and in vivo)
      • Safety Pharmacology
      • Cell and Molecular Biology
      • Discovery Bioanalysis
        • Biomarkers
      • Exploratory Toxicology
        • Toxicogenomics
        • Genetic Toxicology
        • General Toxicology
      • Surgical Models and Medical Device
    • Nonclinical Safety Assessment
      • General Toxicology
      • Safety Pharmacology
      • Genetic Toxicology
      • Regulated Bioanalysis
      • — Biotherapeutics
        • Biomarker
      • DMPK (PK/TK)
      • Developmental and Reproductive Toxicology
      • Carcinogenicity Studies
      • Surgical Models and Medical Device
    • Pathology
      • Histology
      • Digital Pathology
      • Clinical Pathology
      • Medical Device Pathology
    • Bioanalysis
      • Nonregulated Discovery Bioanalysis
      • Regulated Preclinical and Clinical Bioanalysis
      • Biotherapeutics
        • Biomarkers
    • Proteomics
    • Consulting
    • Research Models and Services
  • Insights
  • Contact
  • |
  • Investors
  • Careers
  • VISIT OUR VIRTUAL BOOTH